Can Avid Hyperaccumulating Plants like Hemp be Realistically Used as a Source of Medicinal Cannabinoids? Part 2: The Importance of Testing
The second part of this series examines industrial and medical applications of hemp and emphasize the importance of regular testing for heavy metals to ensure maximum consumer safety.
A Microdosing High is Mostly a Placebo Effect, Psychedelic Study Suggests
People may not have to microdose psychedelics to feel their wellbeing benefits – they just have to believe they’ve microdosed them, according to researchers from Imperial College London.
Cannabis Can Cause “Rebound” Migraine Headaches, Study Finds
Migraine sufferers who use cannabis for pain relief may be at higher odds of developing a “rebound” headache, according to new research from Stanford University.
Virginia Legislature Legalizes Recreational Cannabis, But Sales Won’t Start Until 2024
The legalization bill would allow adults over 21 to possess up to 1 ounce (28 grams) of cannabis from January 1, 2024.
How Does Cannabis Vapor Testing Work?
Cannabis vapor testing is quickly becoming the next frontier of marijuana analysis. But how does it work?
High-CBD Hemp Crops Are Mostly Marijuana, Genetic Study Finds
Hemp crops may have more in common with recreational, “drug-type” varieties of cannabis than previously thought, according to new research from the University of Minnesota.
The Risks and Rewards of Different Cannabis Separation Techniques
Alisia Ratliff, CEO of Victus Capital Ventures, explores the world of cannabis separation techniques – the good, the bad, and the expensive.
Behind the World-First Export of Jamaican Psilocybin Mushrooms
The biotech and life sciences company Mydecine Innovations Group recently announced it had completed its first commercial export of legal psychedelic psilocybin mushrooms from Jamaica to Canada. Technology Networks caught up with the company's chief scientific officer, Rob Roscow, to find out more.
Over Three-quarters of CBD Topicals Don’t Contain Advertised Amounts of CBD, Study Finds
Around 77 percent of tested CBD topical products don't contain the correct amount of CBD advertised on the product’s label, according to a new investigation from Leafreport.
